10x Genomics Corp - TXG Market Capitalization

The price history of 10x Genomics, Inc. (TXG) reflects the dynamics of a business whose US-based facilities produce instruments and consumables for single-cell genomic analysis. Market capitalization stands at 7.54. Intellectual property protections and patents in spatial biology create significant barriers to entry for competitors. Independence from macroeconomic trends and stable demand for innovation transform the company into a reliable defensive asset during recessions.

10x Genomics, Inc. (TXG) maintains high market capitalization stability due to its status as the gold standard in single-cell genomics and the absolute trust of the global scientific community. This indicator, representing the product of the current share price and the total number of outstanding securities, allows for an assessment of the business's aggregate market value and determines its level of protection against default.